UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology Providers

Journal of clinical oncology, 2014-03, Vol.32 (8), p.833-840

2014

Volltextzugriff (PDF)

Genome-Wide Association Studies of Cancer

Journal of clinical oncology, 2010-09, Vol.28 (27), p.4255-4267

2010

Volltextzugriff (PDF)

Adenoma Prevalence in Blacks and Whites Having Equal Adherence To Screening colonoscopy: The National Colonoscopy Study

Clinical gastroenterology and hepatology, 2017-09, Vol.15 (9), p.1469-1470

2017

Volltextzugriff (PDF)

BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews

Clinical cancer research, 2004-05, Vol.10 (9), p.2918-2921

2004

Volltextzugriff (PDF)

Is There a Role for Ovarian Cancer Screening in High-Risk Women?

Journal of clinical oncology, 2017-05, Vol.35 (13), p.1384-1386

2017

Volltextzugriff (PDF)

Genome-wide Association Studies of Cancer Predisposition

Hematology/oncology clinics of North America, 2010-10, Vol.24 (5), p.973-996

2010

Volltextzugriff (PDF)

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017

Journal of the National Comprehensive Cancer Network, 2017-01, Vol.15 (1), p.9-20

2017

Volltextzugriff (PDF)

Management of high, moderate, and low penetrance ovarian cancer susceptibility mutations: an assessment of current risk reduction practices

International journal of gynecological cancer, 2020-10, Vol.30 (10), p.1583-1588

2020

Volltextzugriff (PDF)

Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199)

JNCI cancer spectrum, 2020-02, Vol.4 (1), p.pkz075

2020

Volltextzugriff (PDF)

Improving timeliness and equity in germline genetic testing for pancreatic ductal adenocarcinoma patients: A comparative analysis and future strategies

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.611-611

2024

Volltextzugriff (PDF)

Socioeconomic disparities causing delays in pancreatic cancer germline genetic testing

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.665-665

2023

Volltextzugriff (PDF)

Pancreatic cancer germline mutation report: An in-depth analysis of demographics, mutation profile, and patient survival

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e16233-e16233

2022

Volltextzugriff (PDF)

1164 Adherence to Programmatic Annual Fecal Occult Blood Test (gFOBt) Versus Screening Colonoscopy in African Americans Compared to Whites With Equal Access and Navigation: Observations From National Colonoscopy Study (NCS)

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-213-S-213

2012

Volltextzugriff (PDF)

351 Adherence to Screening in a Randomized Controlled Trial of a One-Time Screening Colonoscopy Versus Program of Annual Fecal Occult Blood Test (gFOBt): Implications of Lower gFOBt Adherence to Screening on Colorectal Cancer Mortality Reduction

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-82-S-83

2012

Volltextzugriff (PDF)

Improved survival for BRCA2-associated serous ovarian cancer compared to both BRCA-negative and BRCA1-associated serous ovarian cancer

Cancer, 2011-12, Vol.118 (15), p.3703-3709

2011

Volltextzugriff (PDF)

Socioeconomic and demographic barriers associated with delays in pancreatic cancer germline genetic testing

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18506-e18506

2023

Volltextzugriff (PDF)

Detection of Proximal Adenomas by Colonoscopy Following Flexible Sigmoidoscopy Depends on the Colonoscopy Referral Algorithm: Analysis of the UK Flexible Sigmoidoscopy Study Algorithm Applied to the U.S. National Colonoscopy Study

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-16-S-16

2011

Volltextzugriff (PDF)

Evaluation of immunohistochemical expression of mismatch repair proteins in endometrioid and seromucinous borderline ovarian tumors a 10-year experience in a large health care institution

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e17557-e17557

2021

Volltextzugriff (PDF)

Proliferation of the Fallopian Tube Fimbriae and Cortical Inclusion Cysts: Effects of the Menstrual Cycle and the Levonorgestrel Intra-Uterine Contraceptive System

Cancer epidemiology, biomarkers & prevention, 2022-09, Vol.31 (9), p.1823-1829

2022

Volltextzugriff (PDF)

Genetic counseling referrals after next generation sequencing testing

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1515-1515

2020

Volltextzugriff (PDF)

Management of high, moderate, and low penetrance ovarian cancer susceptibility gene mutations: An assessment of current practice patterns

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.1536-1536

2019

Volltextzugriff (PDF)

Immune profiling of BRCA-mutated breast cancers

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.585-585

2018

Volltextzugriff (PDF)

Weighing Options for Cancer Risk Reduction in Carriers of BRCA1 and BRCA 2 Mutations

Journal of clinical oncology, 2010-01, Vol.28 (2), p.189-191

2010

Volltextzugriff (PDF)

Clinical characterization of DNA mismatch repair deficiency (MMR-D) in endometrial cancer (EC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1522-1522

2016

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(41)
Buchkapitel
(2)

Sprache

Englisch
(43)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Oncology
(9)
Biological And Medical Sciences
(5)
Gastroenterology And Hepatology
(5)
Humans
(5)
Medical Sciences
(5)
Tumors
(4)
Genetic Predisposition To Disease
(3)
Mutation
(3)
Neoplasms - Genetics
(3)
Ovarian Cancer
(3)
Risk Factors
(3)
Breast Cancer
(2)
Genome-Wide Association Study
(2)
Hematology, Oncology And Palliative Medicine
(2)
Heredity
(2)
Pedigree
(2)
Phenotype
(2)
Risk Assessment
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology Providers

Genome-Wide Association Studies of Cancer

Adenoma Prevalence in Blacks and Whites Having Equal Adherence To Screening colonoscopy: The National Colonoscopy Study

BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews

Is There a Role for Ovarian Cancer Screening in High-Risk Women?

Genome-wide Association Studies of Cancer Predisposition

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017

Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium

Management of high, moderate, and low penetrance ovarian cancer susceptibility mutations: an assessment of current risk reduction practices

Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199)

Improving timeliness and equity in germline genetic testing for pancreatic ductal adenocarcinoma patients: A comparative analysis and future strategies

Socioeconomic disparities causing delays in pancreatic cancer germline genetic testing

Pancreatic cancer germline mutation report: An in-depth analysis of demographics, mutation profile, and patient survival

1164 Adherence to Programmatic Annual Fecal Occult Blood Test (gFOBt) Versus Screening Colonoscopy in African Americans Compared to Whites With Equal Access and Navigation: Observations From National Colonoscopy Study (NCS)

351 Adherence to Screening in a Randomized Controlled Trial of a One-Time Screening Colonoscopy Versus Program of Annual Fecal Occult Blood Test (gFOBt): Implications of Lower gFOBt Adherence to Screening on Colorectal Cancer Mortality Reduction

Improved survival for BRCA2-associated serous ovarian cancer compared to both BRCA-negative and BRCA1-associated serous ovarian cancer

Socioeconomic and demographic barriers associated with delays in pancreatic cancer germline genetic testing

Detection of Proximal Adenomas by Colonoscopy Following Flexible Sigmoidoscopy Depends on the Colonoscopy Referral Algorithm: Analysis of the UK Flexible Sigmoidoscopy Study Algorithm Applied to the U.S. National Colonoscopy Study

Evaluation of immunohistochemical expression of mismatch repair proteins in endometrioid and seromucinous borderline ovarian tumors a 10-year experience in a large health care institution

Proliferation of the Fallopian Tube Fimbriae and Cortical Inclusion Cysts: Effects of the Menstrual Cycle and the Levonorgestrel Intra-Uterine Contraceptive System

Genetic counseling referrals after next generation sequencing testing

Management of high, moderate, and low penetrance ovarian cancer susceptibility gene mutations: An assessment of current practice patterns

Immune profiling of BRCA-mutated breast cancers

Weighing Options for Cancer Risk Reduction in Carriers of BRCA1 and BRCA 2 Mutations

Clinical characterization of DNA mismatch repair deficiency (MMR-D) in endometrial cancer (EC)

Aktive Filter

Suchergebnisse filtern